Literature DB >> 23335088

GDF15-mediated upregulation of ferroportin plays a key role in the development of hyperferritinemia in children with hemophagocytic lymphohistiocytosis.

Jian-Rong Wu1, Li-Xing Yuan, Zhi-Gui Ma, Xiao-Xi Chen, Ling Gu, Ju Gao.   

Abstract

BACKGROUND: Growth differentiation factor 15 (GDF15), a divergent TGFβ superfamily, has recently been implicated in the modulation of iron homeostasis, acting as an upstream negative regulator of hepcidin, the key iron regulatory hormone produced primarily by hepatocytes. However, little is known about possible roles that GDF15 might play in the regulation of iron homeostasis and development of hyperferritinemia in children with hemophagocytic lymphohistiocytosis (HLH). PROCEDURES: We compared serum GDF15 level and mRNA expressions of GDF15 and key molecules of iron metabolism, and made correlations between their expressions in children with HLH and control children.
RESULTS: Serum GDF15 level was remarkably higher in HLH group than that in controls, with median serum concentration of 1,700 and 260 pg/ml, respectively (P < 0.001). In addition, GDF15 mRNA was significantly upregulated but independent of hypoxia-inducible factor-mediated oxygen signaling pathway. More importantly, GDF15 induction was positively correlated to upregulation of ferroportin, the only cellular iron exporter, and to upregulation of ferritin heavy chain.
CONCLUSIONS: Our study suggests that GDF15 induction helps suppress further activation of macrophages in stressful physiologic states as HLH, and is intimately implicated in the development of hyperferritinemia by modulating the hepcidin-ferroportin axis, resulting in enhanced ferroportin-mediated iron efflux.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23335088     DOI: 10.1002/pbc.24373

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  4 in total

Review 1.  Mechanistic Insights in Hemophagocytic Lymphohistiocytosis: Subsequent Acute Hepatic Failure in a Multiple Myeloma Patient Following Therapy with Ixazomib-Lenalidomide-Dexamethasone.

Authors:  Catalin Constantinescu; Bobe Petrushev; Ioana Rus; Horia Stefanescu; Otilia Frasinariu; Simona Margarit; Delia Dima; Ciprian Tomuleasa
Journal:  J Pers Med       Date:  2022-04-23

Review 2.  Haemophagocytic lymphohistiocytosis (HLH) following allogeneic haematopoietic stem cell transplantation (HSCT)-time to reappraise with modern diagnostic and treatment strategies?

Authors:  Robert David Sandler; Stuart Carter; Harpreet Kaur; Sebastian Francis; Rachel Scarlett Tattersall; John Andrew Snowden
Journal:  Bone Marrow Transplant       Date:  2019-08-27       Impact factor: 5.483

3.  Haemophagocytic Lymphohistiocytosis as a Complication of Israeli Spotted Fever.

Authors:  Maria Margarida Andrade; Ana Gorgulho; Rita Tinoco Magalhães; Rita Valadas; Luís Miguel Pereira; Sara Freire; Diogo Cruz
Journal:  Eur J Case Rep Intern Med       Date:  2022-01-17

4.  Comparison of the clinical features and outcome of children with hemophagocytic lymphohistiocytosis (HLH) secondary to visceral leishmaniasis and primary HLH: a single-center study.

Authors:  Mahdi Shahriari; Mohammadreza Bordbar; Hadi Mottaghipisheh; Kurosh Kalantar; Ali Amanati; Mansoureh Shokripour; Omid Reza Zekavat; Soheila Zareifar; Mehran Karimi; Sezaneh Haghpanah
Journal:  BMC Infect Dis       Date:  2021-08-02       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.